Source comparison
Quickcomparison
Dose Range TB-500 2–5 mg BPC-157 250–500 mcg Frequency Twice weekly Once daily Administration Subcutaneous injection Cycle Length 4-6 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Strong preclinical (extensive animal s
This comparison does not assign a generated winner or score.
- Dose Range
- TB-500
- 2–5 mg
- BPC-157
- 250–500 mcg
- Frequency
- Twice weekly
- Once daily
- Administration
- Subcutaneous injection
- Cycle Length
- 4-6 weeks
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Moderate human trials (Phase 1-2)
- Strong preclinical (extensive animal studies)
- Efficacy